Benchmark analyst Robert Wasserman initiated coverage of Kamada (KMDA) with a Buy rating and $15 price target
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on KMDA:
- Kamada Expands Plasma Collection Operations with New San Antonio Center
- Kamada opens third plasma collection center in San Antonio, Texas
- Kamada: A Growth-Oriented Investment with Strong Financials and Strategic Expansion Plans
- Kamada Ltd’s Growth at Risk: Manufacturing Capacity and Expansion Challenges Loom Large
- Kamada Ltd. Reports Record 2024 Financial Results